Stay updated with breaking news from Braf Mutation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Michael Postow, MD, shares a preview of an upcoming Peer Exchange series on current testing and treatment approaches for metastatic melanoma, highlighting recent key data from ESMO 2023.
Following the recent FDA approval of Braftovi with Mektovi for some patients with NSCLC and a BRAF V600E mutation, a lung cancer expert explains the science behind the news.
An expert panel analyzes BRAF/MEK dual inhibitor therapy for the treatment of melanoma.
Anna C. Pavlick, DO, discusses factors that impact treatment selection for patients with melanoma.
Skin cancer experts discuss prognosis and unmet needs in the cutaneous squamous cell carcinoma and melanoma treatment spaces.